XTalks

APRIL 26, 2024

Wegovy nabbed a second US Food and Drug Administration (FDA) approval in March for reducing the risk of cardiovascular death, heart attack and stroke in adult patients with cardiovascular disease who have obesity or are overweight. The company received FDA approval for Ozempic in 2017 followed by Wegovy’s approval in 2021.

Drugs 52

Drugs FDA Approval Manufacturing Production 52

Bioengineer

JULY 23, 2021

The phase 2 trial result led to Food and Drug Administration (FDA) approval of Loncastuximab tesirine as a single agent. Each year, MUSC educates and trains more than 3,000 students and nearly 800 residents in six colleges: Dental Medicine, Graduate Studies, Health Professions, Medicine, Nursing and Pharmacy.

Trials 52

Trials Antibody Drugs Clinical Trials 52

pharmaphorum

DECEMBER 7, 2021

Scientists in the US have found that people who use Viagra for erectile dysfunction seem to have a lower risk of developing Alzheimer’s disease – a link that they say should be examined more closely in clinical trials.

Drugs 52

Drugs Clinical Trials Clinical Trials Scientist 52

The Pharma Data

JANUARY 12, 2021

Casirivimab and imdevimab injection is an investigational combination therapy and has been authorized by FDA for the emergency use described above. Casirivimab and imdevimab injection is not FDA approved for any use. 360bbb-3(b) (1), unless the authorization is terminated or revoked sooner.

Antibody 52

Antibody Production Manufacturing Clinical Trials 52

The Pharma Data

NOVEMBER 20, 2020

To develop this novel medicine, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19. Source: Regeneron. Posted: November 2020.

Antibody 52

Antibody Production Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 24, 2021

Dr. Van Slyke is a biotechnology entrepreneur, scientist, and serial inventor. Sairiyo is advancing the clinical development of its lead drug candidate, Cepharanthine, a repurposed and reformulated naturally derived compound for the potential treatment of cancer, neurological, inflammatory and infectious diseases.

Drugs 52

Drugs Containment Development Clinical Development 52

The Pharma Data

NOVEMBER 5, 2020

FDA accepted for priority review Libtayo ® (cemiplimab-rwlc) for both advanced non-small cell lung cancer and basal cell carcinoma. FDA approved Inmazeb for Ebola ( Zaire ebolavirus). REGN-COV2 trial in the COVID-19 outpatient setting met primary and key secondary endpoints. Regeneron Pharmaceuticals, Inc.

Sales 40

Sales Production Manufacturing Antibody 40

The Pharma Data

NOVEMBER 21, 2020

To develop REGEN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 40

Antibody Production Clinical Trials Clinical Trials 40

The Pharma Data

DECEMBER 29, 2020

To develop this novel medicine, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 52

Antibody Trials Production Clinical Trials 52

Pfizer

SEPTEMBER 27, 2022

It’s this investment in innovation that enables our scientists to make dramatic strides in healthcare. Biosimilars are FDA approved, and often offer a lower-cost alternative to biologic therapies that treat challenging diseases like cancer, diabetes, and rheumatoid arthritis.

Medicine 40

Medicine Vaccination Vaccine Gene Therapy 40

The Pharma Data

MAY 13, 2021

I’ll also show you why their top scientists are now saying that this breakthrough treatment could replace traditional medical approaches for a wide range of painful conditions… What this means is that you can now say goodbye to your daily aches and pains without harmful drugs or having to resort to painful surgery.

Production 52

Production Pharmacy Doctors Doctor 52

The Pharma Data

OCTOBER 14, 2020

Food and Drug Administration (FDA) approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection. TARRYTOWN, N.Y., NASDAQ: REGN) announced today that the U.S.

FDA Approval 52

FDA Approval Antibody Production Trials 52

XTalks

MARCH 3, 2025

Related: AstraZeneca Strengthens Canadian Life Sciences Footprint with $570M Investment The expansion is expected to generate over 3,000 high-skilled jobs for scientists, engineers, lab technicians and operations personnel in addition to approximately 10,000 construction roles across the four new sites. billion and Zepbound hitting $4.9

Manufacturing 72

Manufacturing Pharmacy Life Science Drugs 72

The Pharma Data

MAY 13, 2021

. Third time’s the charm as Heron wins FDA nod for non-opioid anesthetic Zynrelef ( Endpoints ). Amgen, AstraZeneca bolster their case for breakthrough asthma program as FDA considers taking up a review ( Endpoints ). Top scientists question the need for COVID-19 booster shots ( Reuters ).

FDA Approval 52

FDA Approval Vaccination Vaccine Drugs 52